Alejandro A. Gru

Columbia University Irving Medical Center

Also affiliated with Columbia University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas”.

Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas

Nature Communications(2020)10.1038/s41467-020-15572-7

N/A

0DataRank · unranked

100 citations

Peter Doukas, Maria E. Martínez Escala, Kimberly G. Ringbloom, David Shih, Jingyi Yang +19 more

Primary cytotoxic T-cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway

Blood(2021)10.1182/blood.2021012536

N/A

0DataRank · unranked

30 citations

Mark G. Evans, Lei Yang, Spencer Ng, Caroline Snowden, Michael S. Khodadoust +18 more

Loss of miR-1469 expression mediates melanoma cell migration and invasion

PLoS ONE(2021)10.1371/journal.pone.0256629

N/A

0DataRank · unranked

6 citations

Zoe Barricklow, Emily Schwarz, Maribelle Moufawad, John H. Howard, Lianbo Yu +4 more

PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.08.036

N/A

0DataRank · unranked

55 citations

Guangping Sun, Hiroto Nakano, Elizabeth Schmitz, Anthony Cruz, Charles G. Fisher +91 more

Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas

OncoImmunology(2023)10.1080/2162402x.2022.2164476

N/A

0DataRank · unranked

11 citations

Sarah E. Gradecki, Priya Katyal, Kevin Lynch, Anne M. Stowman, Alejandro A. Gru +4 more

398 | LACUTAMAB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MYCOSIS FUNGOIDES: LONG TERM FOLLOW‐UP AND TRANSLATIONAL DATA FROM THE TELLOMAK PHASE 2 TRIAL

Hematological Oncology(2025)10.1002/hon.70094_398

N/A

0DataRank · unranked

0 citations

Martine Bagot, C. Ram‐Wolf, Auris Huen, Stéphane Dalle, Neha Mehta–Shah +16 more